Lost to Follow-Up: Complications of an Invasive Giant Prolactinoma

Lost to follow-up.

results gained from primary attenders at a tate review clinic after shoulder surgery may not be representative of the outcome: the average self-assessment of the non-attenders was lower by one class. Age differences have been shown to affect the self assessment of health (Idler 1993). In this study, however, with an average age of 5 1.1 years among attenders and 48.8 years in non-attenders, thi...

Cabergoline Treatment in Invasive Giant Prolactinoma

Patients with invasive giant prolactinoma suffer from a constellation of symptoms including headache, blurred vision, lethargy, and sexual dysfunction. Cabergoline, a potent dopamine agonist, is a known medication prescribed for the treatment of invasive giant prolactinoma. Here, we report a case of invasive giant prolactinoma in a 52-year-old Saudi male with dramatic response to cabergoline tr...

Remarkable remission of an invasive giant prolactinoma under high-dose bromocriptine monotherapy.

Patients lost to follow - up after midurethral sling surgery :

ARTICLE INFO ______________________________________________________________ ______________________ Purpose: To assess the ratio of patients lost to follow-up (FU) after midurethral sling surgery, to evaluate their success rate and current status, and to identify the reasons for FU loss. Materials and Methods: Two-hundred thirty-eight patients who received trans-obturator tape (TOT) surgery were...

Women with abnormal screening mammography lost to follow-up

Breast cancer has the highest incidence among all cancers for women in Taiwan. The current screening policy in Taiwan suggested a biennial mammography for all women 40 to 69 years of age. A recommendation for additional testing is recommended for women with a BI-RADS result of 0 or 4; a request made via postal mail. Approximately 20% of high-risk patients do not receive additional follow-up. Th...